![Jonathan Yingling](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Yingling
Direttore Tecnico/Scientifico/R&S presso ARCUS BIOSCIENCES, INC.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Christopher Boerner | M | 53 | 9 anni | |
Terry Rosen | M | 65 | 9 anni | |
Juan Jaen | M | 66 | 9 anni | |
Jennifer Jarrett | F | 53 | 7 anni | |
Clarence Machado | M | 60 | 5 anni | |
David Lacey | M | 71 | 4 anni | |
Dimitry Nuyten | M | 48 | 8 anni | |
Alexander Azoy | M | 48 | 4 anni | |
Nicole Lambert | F | 50 | 3 anni | |
Robert Goeltz | M | 51 | 4 anni | |
Antoni Ribas | M | 58 | 5 anni | |
Andrew Perlman | M | 76 | 4 anni | |
Yasunori Kaneko | M | 69 | 9 anni | |
Kathryn Falberg | F | 63 | 7 anni | |
Merdad Parsey | M | 61 | 4 anni | |
Linda Higgins | M | 62 | 3 anni | |
Steve Young | M | 55 | 8 anni | |
Yvonne Gehring | F | - | 8 anni | |
Johanna Mercier | F | 54 | - | |
Carolyn Tang | F | 45 | 7 anni | |
Eric Matthews | M | - | 5 anni | |
Zack Newman | M | - | 11 anni | |
Holli Kolkey | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Sudhir D. Agrawal | M | 70 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 32 anni |
Louis J. Arcudi | M | 63 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 11 anni |
James Cornelius | M | 81 | 10 anni | |
Thomas Lynch | M | 63 | 5 anni | |
Jason Barker | M | 54 | 1 anni | |
John E. Celentano | M | 64 | 31 anni | |
Bryant Lim | M | 53 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 4 anni |
Jason Haddock | M | 54 | 14 anni | |
Melissa C. Paoloni | M | - | 4 anni | |
Youssef El Zein | M | 75 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 25 anni |
Michael Quigley | M | 42 | - | |
Cristina Csimma | M | 65 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | - |
Kelvin Neu | M | 50 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 5 anni |
Brian Daniels | M | 65 | 14 anni | |
Michael Dougherty | M | 66 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | - |
Mark Joseph Casey | M | 60 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 3 anni |
Béatrice J. Cazala | F | 67 | 32 anni | |
Julian Baker | M | 57 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 4 anni |
William Reardon | M | 78 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 17 anni |
Charles Sigal | M | 72 | 16 anni | |
Carol Schafer | F | 60 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 4 anni |
Dinesh C. Paliwal | M | 67 | 8 anni | |
Howard H. Pien | M | 66 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | - |
Danielle Halstrom | F | - | 7 anni | |
Robert Wollin | M | 48 | 4 anni | |
Elizabeth Ingram | F | 59 | 2 anni | |
David Berman | M | - | 10 anni | |
Kevin Trapp | M | - | 2 anni | |
Mark Neumann | M | 61 | 26 anni | |
Elizabeth A. Tarka | M | 57 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 2 anni |
Ronald Peck | M | 58 | 4 anni | |
Anthony P Waclawski | M | 62 | 6 anni | |
Kartik Krishnan | M | - | 3 anni | |
Sanjay Keswani | M | 54 | 4 anni | |
Tamar Thompson | F | 50 | 4 anni | |
Allison Luo | M | 50 | 8 anni | |
Nick Giafis | M | - | 3 anni | |
Lynn Sadowski Mason | F | 45 | 2 anni | |
James Cassidy | M | 65 | 3 anni | |
Kinnari Patel | M | 45 | 4 anni | |
Rebecca Drain | F | 61 | 3 anni | |
Vicki Goodman | M | 55 | 5 anni | |
Joseph Carroll | M | - |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 4 anni |
Timothy Sullivan | M | 54 | 3 anni | |
Ronald Shazer | M | 56 | 2 anni | |
Steven Binder | M | 61 | 1 anni | |
Ronald Marcus | M | 65 | 22 anni | |
Joanna Horobin | M | 69 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 4 anni |
Don Soland | M | 65 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 2 anni |
Lubor Gaal | M | 56 | 9 anni | |
Erin E. Lanciani | F | 55 | 5 anni | |
Patrick Loustau | M | 61 | 4 anni | |
Paul Biondi | M | 54 | 13 anni | |
Michelle Werner | F | 48 | 10 anni | |
Clifford Bechtold | M | - | 2 anni | |
William Grossman | M | 54 | 2 anni | |
Jon Wigginton | M | 62 | 5 anni | |
Elliott Levy | M | 65 | 17 anni | |
Desiree Luthman | M | 65 | 2 anni | |
Marco Londei | M | 68 | 2 anni | |
Paul Daruwala | M | 55 | 2 anni | |
Thomas Gibbs | M | 52 | 5 anni | |
Joseph Leveque | M | 63 | 4 anni | |
Rupert Vessey | M | 59 | 8 anni | |
Vladimir Coric | M | 53 | 8 anni | |
Linda Kozick | F | 66 | 4 anni | |
Lena Elisabeth Svanberg | M | 63 | 7 anni | |
Robert Berman | M | 61 | 10 anni | |
Kimberly Gentile | F | 56 | 14 anni | |
Patricia Carlos | F | - | 3 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 93 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jonathan Yingling
- Contatti personali